icon-folder.gif   Conference Reports for NATAP  
 
  EACS - 12th European AIDS Conference
November 11-14, 2009
Cologne, Germany
Back grey_arrow_rt.gif
 
 
 
Pros and Cons of Boosted PI Monotherapy
 
 
  Reported by Jules Levin
EACS Cologne Nov 11-14 2009
 
Presented in an oral talk by Dr. Jose R Arribas alter the several oral slide presentations on PI monotherapy
 
HIV UNIT

image002.gif

image004.gif

XV WAC 2004 MoOrB1057. 4th IAS 2007 WEPEB034. J Infect Dis. 2008 15;198:234. JAIDS 2005;40:280-287. AIDS. 2008;11:F1-9. XVI IAC 2006; #TUAB0102. EACS 2009 PS4/5 .J Infect Dis. 2009 15;199:866. AIDS 2007; 21:1309-1315. JAIDS 2007;44:417. EACS 2009 PS4/6. 5th IAS 2009 AIDS 2009 (in press)

image006.gif

image008.gif

Arribas JR. et al., 11th EACS, Madrid, 2007, # PS3/1
 
Systematic review of boosted PI monotherapy

image010.gif

Bierman WF. AIDS 2009, 22:1-13

image012.gif

image014.gif

Pulido F et al. AIDS. 2008 Jan 11;22(2):F1-9.

image016.gif

image018.gif

image020.gif

image022.gif

Arribas JR. et al., 11th EACS, Madrid, 2007, # PS3/1 OK04
 
Single Genome Sequencing Analyisis. OK04

image024.gif

Mckinnon J et al. XVII International HIV Drug Resistance Workshop. Sitges Abstract #80
 
Comparison of Suppressed HIV RNA levels between Treatment Arms by Study Week

image026.gif

McKinnon J et al. AIDS 2006 28;20:2331-5

image028.gif

OK04: Risk factors for loss of virological suppression

image030.gif

Pulido F. Antivir Ther. 2009;14:195-201 Lopinavir monotherapy and CSF replication

image032.gif

Yeh et al. CROI 2007

image034.gif

image036.gif

Canestri A et al. CROI 2009. # 484

image038.gif

image040.gif

Yeh et al. 11th EACS. 2007

image042.gif

Cameron DW et al., 14th CROI, Los Angeles, February 2007, Oral#44LB M03-613

image044.gif

Arribas JR. GESIDA 2009. Abstract PO071

image046.gif

image048.gif

EACS Guidelines 2009.